IHS Chemical Week

Regions :: China

Sinopec and Zhejiang Hengyi Invest $567 Million in Caprolactam JV

3:59 AM MST | December 16, 2011 | Deepti Ramesh

Sinopec says its Sinopec Baling (Yunxi, Hunan Province, China) subsidiary has established a joint venture company with Zhejiang Hengyi Group (Xiaoshan, Zhejiang Province, China) to manufacture caprolactam at Xiaoshan. The jv company Zhejiang Baling Hengyi Caprolactam Co. was established on December 6. Sinopec Baling and Zhejiang Hengyi are investing a total of Rmb3.6 billion ($567 million) in the project which will produce 200,000 m.t./year of caprolactam. The plant is expected to become operational in the second quarter of...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa